載入中
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
前收盤價
US$3.41
−US$0.03 · -0.87%
盤中時間採用ET。市場資料可能有所延遲。
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
日內區間
目前US$3.41
52週區間
目前US$3.41
盤中時間採用ET。市場資料可能有所延遲。
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
日內區間
目前US$3.41
52週區間
目前US$3.41
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 394.4萬 USD | 327.7萬 USD | 292.8萬 USD | 69.1萬 USD | 16萬 USD |
| 銷貨成本 | 158.6萬 USD | 156.6萬 USD | 168.7萬 USD | 133.2萬 USD | 5.5萬 USD |
| 毛利 | 235.8萬 USD | 171.1萬 USD | 124.1萬 USD | −64.1萬 USD | 10.5萬 USD |
| 研究與開發 | 214.9萬 USD | 260.3萬 USD | 316.3萬 USD | 282.8萬 USD | 171.8萬 USD |
| 銷售、一般及管理費用 | 1300.1萬 USD | 1287.4萬 USD | 1380.5萬 USD | 1525.6萬 USD | 484.8萬 USD |
| 營業費用 | 1515萬 USD | 1547.7萬 USD | 1696.8萬 USD | 1808.4萬 USD | 656.6萬 USD |
| 利息支出 | — | 3.4萬 USD | 2.1萬 USD | 35.4萬 USD | 62.1萬 USD |
| 折舊和攤銷 | 53萬 USD | 65.5萬 USD | 42.6萬 USD | 28.9萬 USD | 11.4萬 USD |
| 營業利益 | −1279.2萬 USD | −1376.6萬 USD | −1572.7萬 USD | −1872.5萬 USD | −646.1萬 USD |
| 淨利 | −1255.6萬 USD | −1367.3萬 USD | −1558.1萬 USD | −1891.7萬 USD | −704.8萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$2.25
下跌空間 34.02%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2026年8月10日 | 1:35 | — | — |
股票分割 | 2024年9月6日 | 1:8 | — | — |
股票分割 | 2023年11月2日 | 1:10 | — | — |
已生效 2026年8月10日
1:35
已生效 2024年9月6日
1:8
已生效 2023年11月2日
1:10
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
